Somerset Trust’s Gilead Sciences GILD Stock Holding History

Somerset Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$983K	Buy	7,778 +80	+1%	+$10.5K	0.28%	72
2026 Q1	$1.07M	Buy	7,698 +106	+1%	+$14.8K	0.33%	64
2025 Q4	$932K	Buy	7,592 +25	+0.3%	+$3.04K	0.29%	67
2025 Q3	$840K	Sell	7,567 -133	-2%	-$15.1K	0.26%	67
2025 Q2	$854K	Sell	7,700 -103	-1%	-$11K	0.28%	66
2025 Q1	$874K	Sell	7,803 -91	-1%	-$9.39K	0.31%	63
2024 Q4	$729K	Sell	7,894 -44	-0.6%	-$3.96K	0.27%	67
2024 Q3	$666K	Sell	7,938 -10	-0.1%	-$763	0.25%	70
2024 Q2	$545K	Sell	7,948 -20	-0.3%	-$1.33K	0.22%	83
2024 Q1	$584K	Sell	7,968 -103	-1%	-$7.92K	0.24%	78
2023 Q4	$654K	Sell	8,071 -472	-6%	-$36.7K	0.29%	64
2023 Q3	$640K	Sell	8,543 -126	-1%	-$9.69K	0.29%	63
2023 Q2	$668K	Sell	8,669 -394	-4%	-$31.4K	0.29%	65
2023 Q1	$752K	Sell	9,063 -299	-3%	-$24.8K	0.33%	62
2022 Q4	$804K	Buy	9,362 +80	+0.9%	+$6.33K	0.34%	63
2022 Q3	$573K	Sell	9,282 -208	-2%	-$13.1K	0.27%	65
2022 Q2	$587K	Buy	9,490 +23	+0.2%	+$1.42K	0.26%	66
2022 Q1	$563K	Buy	9,467 +1,755	+23%	+$112K	0.22%	71
2021 Q4	$560K	Sell	7,712 -2,154	-22%	-$148K	0.2%	73
2021 Q3	$689K	Sell	9,866 -266	-3%	-$18.7K	0.28%	63
2021 Q2	$698K	Buy	10,132 +49	+0.5%	+$3.27K	0.29%	64
2021 Q1	$652K	Sell	10,083 -43	-0.4%	-$2.77K	0.28%	65
2020 Q4	$590K	Buy	10,126 +4	+0%	+$241	0.27%	64
2020 Q3	$640K	Buy	10,122 +44	+0.4%	+$3.05K	0.32%	60
2020 Q2	$775K	Sell	10,078 -385	-4%	-$29.5K	0.41%	60
2020 Q1	$782K	Sell	10,463 -2,298	-18%	-$159K	0.51%	54
2019 Q4	$829K	Sell	12,761 -280	-2%	-$18.2K	0.41%	72
2019 Q3	$827K	Sell	13,041 -85	-0.6%	-$5.56K	0.44%	71
2019 Q2	$887K	Sell	13,126 -311	-2%	-$20.5K	0.46%	71
2019 Q1	$874K	Buy	13,437 +188	+1%	+$12.5K	0.46%	68
2018 Q4	$829K	Sell	13,249 -3,205	-19%	-$224K	0.48%	72
2018 Q3	$1.27M	Sell	16,454 -157	-0.9%	-$11.9K	0.63%	68
2018 Q2	$1.18M	Sell	16,611 -1,596	-9%	-$113K	0.63%	69
2018 Q1	$1.37M	Sell	18,207 -245	-1%	-$19.5K	0.71%	60
2017 Q4	$1.32M	Sell	18,452 -1,505	-8%	-$114K	0.66%	66
2017 Q3	$1.62M	Sell	19,957 -2,387	-11%	-$183K	0.86%	44
2017 Q2	$1.58M	Sell	22,344 -203	-0.9%	-$13.5K	0.86%	40
2017 Q1	$1.53M	Sell	22,547 -284	-1%	-$20K	0.86%	41
2016 Q4	$1.64M	Sell	22,831 -1,144	-5%	-$85K	0.97%	33
2016 Q3	$1.9M	Buy	23,975 +4,565	+24%	+$371K	1.13%	26
2016 Q2	$1.62M	Buy	19,410 +3,806	+24%	+$338K	1%	30
2016 Q1	$1.43M	Buy	15,604 +5	+0%	+$451	0.95%	38
2015 Q4	$1.58M	Buy	15,599 +40	+0.3%	+$4.16K	1.04%	29
2015 Q3	$1.53M	Buy	15,559 +128	+0.8%	+$14.2K	1.07%	24
2015 Q2	$1.81M	Buy	15,431 +47	+0.3%	+$5.14K	1.18%	22
2015 Q1	$1.51M	Sell	15,384 -56	-0.4%	-$5.69K	1%	29
2014 Q4	$1.46M	Sell	15,440 -15,671	-50%	-$1.62M	0.97%	32
2014 Q3	$3.31M	Sell	31,111 -313	-1%	-$30.6K	2.31%	4
2014 Q2	$2.6M	Buy	31,424 +12,231	+64%	+$952K	1.85%	9
2014 Q1	$1.36M	Sell	19,193 -366	-2%	-$28.7K	1.04%	29
2013 Q4	$1.47M	Buy	+19,559	New	+$1.36M	1.12%	29

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Somerset Trust's GILD Position: Q2 2026 in Review

Somerset Trust increased its Gilead Sciences (GILD) stake by 1% in Q2 2026, buying an estimated $10.5K and bringing the position to 7,778 shares worth $983K. The position accounts for 0.28% of the portfolio, ranked #72.

Somerset Trust first reported a position in GILD in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.31M in Q3 2014. 425 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Somerset Trust held 7,778 shares of Gilead Sciences worth $983K as of Q2 2026.
Somerset Trust bought 80 Gilead Sciences shares in Q2 2026, an estimated $10.5K.
Gilead Sciences made up 0.28% of Somerset Trust's portfolio in Q2 2026, its #72 holding.
Somerset Trust first reported a position in Gilead Sciences in Q4 2013 and has held it in 51 quarters since.
Somerset Trust's Gilead Sciences position peaked at $3.31M in Q3 2014.
425 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.